tiprankstipranks
Synthomer PLC (GB:SYNT)
LSE:SYNT

Synthomer (SYNT) AI Stock Analysis

93 Followers

Top Page

GB:SYNT

Synthomer

(LSE:SYNT)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
53.00 p
▲(36.95% Upside)
Action:ReiteratedDate:12/07/25
Synthomer's overall stock score reflects significant financial challenges, with negative profitability and high leverage being major concerns. Technical analysis provides mixed signals, with short-term bullish momentum but longer-term bearish trends. Valuation is weak due to a negative P/E ratio. However, positive corporate events, such as insider buying and strategic appointments, offer some optimism for future prospects.
Positive Factors
Innovative Product Offerings
Synthomer's emphasis on innovative and high-performance products positions it well to meet evolving customer needs, supporting long-term growth.
Negative Factors
High Debt Levels
High leverage can limit financial flexibility and increase risk, potentially impacting Synthomer's ability to invest in growth opportunities.
Read all positive and negative factors
Positive Factors
Negative Factors
Innovative Product Offerings
Synthomer's emphasis on innovative and high-performance products positions it well to meet evolving customer needs, supporting long-term growth.
Read all positive factors

Synthomer (SYNT) vs. iShares MSCI United Kingdom ETF (EWC)

Synthomer Business Overview & Revenue Model

Company Description
Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic poly...
How the Company Makes Money
Synthomer generates revenue through the sale of its wide range of polymer products, which are sold primarily to industrial customers in various sectors including construction, textiles, and coatings. The company's revenue model is largely based on...

Synthomer Financial Statement Overview

Summary
Synthomer's financial performance is under pressure with declining profitability, negative net income, and high leverage. The income statement, balance sheet, and cash flow statement all indicate significant challenges, including negative free cash flow and high debt levels.
Income Statement
45
Neutral
Balance Sheet
50
Neutral
Cash Flow
40
Negative
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.86B1.99B1.97B2.33B2.14B1.64B
Gross Profit336.90M337.70M307.30M281.00M569.70M336.70M
EBITDA70.30M83.00M113.40M139.40M394.40M254.50M
Net Income-83.60M-72.60M-67.00M-32.50M208.70M3.10M
Balance Sheet
Total Assets2.45B2.54B2.71B3.15B2.55B2.13B
Cash, Cash Equivalents and Short-Term Investments266.40M225.80M371.30M227.70M505.30M201.80M
Total Debt960.60M878.70M926.30M1.30B663.00M719.00M
Total Liabilities1.46B1.43B1.54B2.11B1.52B1.50B
Stockholders Equity983.70M1.09B1.15B1.02B1.02B615.00M
Cash Flow
Free Cash Flow-82.70M-124.10M66.00M45.00M193.20M134.90M
Operating Cash Flow14.90M-33.50M150.00M135.80M275.40M188.70M
Investing Cash Flow-70.60M-61.70M107.70M-850.10M-78.60M-365.80M
Financing Cash Flow44.80M-45.90M-90.90M414.50M118.50M273.20M

Synthomer Technical Analysis

Technical Analysis Sentiment
Positive
Last Price38.70
Price Trends
50DMA
31.86
Positive
100DMA
45.32
Negative
200DMA
59.09
Negative
Market Momentum
MACD
3.23
Negative
RSI
64.13
Neutral
STOCH
65.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SYNT, the sentiment is Positive. The current price of 38.7 is above the 20-day moving average (MA) of 26.43, above the 50-day MA of 31.86, and below the 200-day MA of 59.09, indicating a neutral trend. The MACD of 3.23 indicates Negative momentum. The RSI at 64.13 is Neutral, neither overbought nor oversold. The STOCH value of 65.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:SYNT.

Synthomer Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
£500.68M22.536.40%9.48%0.58%61.58%
70
Outperform
£174.66M8.6918.25%2.00%15.56%-92.94%
66
Neutral
£4.02B60.706.17%3.45%2.36%-13.99%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
58
Neutral
£866.19M-28.06-6.85%1.34%-11.78%-92.61%
51
Neutral
£63.30M-1.25-7.26%-4.41%2.29%
46
Neutral
£257.58M131.420.79%2.44%-4.71%86.21%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:SYNT
Synthomer
38.70
-46.10
-54.36%
GB:CRDA
Croda International
2,877.00
364.95
14.53%
GB:ELM
Elementis
152.40
40.15
35.76%
GB:ESNT
Essentra
90.60
0.49
0.55%
GB:VCT
Victrex
575.00
-90.05
-13.54%
GB:ZTF
Zotefoams
358.00
134.15
59.93%

Synthomer Corporate Events

Business Operations and StrategyFinancial DisclosuresM&A Transactions
Synthomer Lifts Margins and Cash Flow Despite Softer Demand and Tariff Hit
Positive
Jan 29, 2026
Synthomer expects 2025 revenue of about £1.74bn and EBITDA of £135m–£138m for its continuing operations, slightly down on 2024 but in line with expectations, as cost-cutting and a shift toward higher-margin speciality solution...
Business Operations and StrategyPrivate Placements and Financing
Synthomer Announces Receivables Purchasing Agreement to Enhance Financial Flexibility
Positive
Dec 18, 2025
Synthomer has entered a trade receivables purchasing arrangement with Rainbow State Limited, a subsidiary of its major shareholder KLK Group. This temporary arrangement will provide Synthomer with short-term financial flexibility and ensure suffic...
Business Operations and StrategyExecutive/Board Changes
Synthomer Announces Board Changes to Strengthen Governance
Neutral
Dec 12, 2025
Synthomer plc announced changes to its Board, with Ian Tyler and Roberto Gualdoni stepping down as independent Non-Executive Directors. Janet Ashdown will succeed Ian as Senior Independent Director, and Jonathan Silver will become Chair of the Aud...
Other
Synthomer CEO Invests in Company Shares
Positive
Nov 12, 2025
Synthomer PLC announced that its CEO, Michael Willome, has purchased 63,000 ordinary shares of the company at a price of £0.4918 per share, totaling £30,983.40. This transaction, conducted on the London Stock Exchange, signifies a potent...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025